- Email: [email protected]
Continued growth for prominent
June 2007
Pump Industry Analyst
NEWS
MHI TO LICENSE PUMP TECHNOLOGY TO BHEL Japan’s Mitsubishi Heavy Industries Ltd (MHI) and Bharat Heavy Electricals Ltd (BHEL), a governmentowned company in India, have signed an agreement under which MHI will license selected pump technologies for thermal power generation plant use. MHI will license design and production technologies for boiler feed water pumps, boiler feed water booster pumps, circulating water pumps and condensate pumps for subcritical and supercritical pressure thermal power generation plants with generation capacities of 500–1000 MW. MHI is the first Japanese company to license pump technology to a power plant maker in India. Delivery of the first pump unit produced under the agreement is expected in late 2009. BHEL has been aiming to manufacture and supply its own key equipment for power plants, including pumps, in order to accommodate plans to build supercritical pressure power plants with more than 500MW power generation capacity. MHI meanwhile has been seeking to establish a foothold into the brisk Indian power plant market.
NEW CARDO ON TRACK Cardo is developing according to plan with a strong platform for continued development as a customeroriented solution provider and an industrial group with good growth. This was the message delivered by Cardo’s president and chief executive officer (CEO) Peter Aru at a Capital
16
Markets Day in Stockholm for analysts, investors and journalists. Aro said that a new Cardo is emerging - an international, streamlined industrial group with strong brands, offering market-leading products and value-adding solutions to selected customers. “Cardo’s strategy involves targeting large international and national customers and a greater focus on value-adding solutions, where service is an important business driver for continued growth,” said Peter Aru. “We can see that the implementation of the new strategy is going according to plan and that the group has been able to report increased growth seven quarters in a row.” “An important contribution to growth will be made through our increased presence in the new emerging markets in Asia, eastern Europe and Latin America. Compared with the previous year, half of the increase in the inflow of orders during the first quarter of 2007 came from markets outside the EU,” declared Peter Aru. Tomas Wängberg, who recently took over as head of Wastewater Technology Solutions, reported a positive earnings trend, as a result of, among other things, a greater focus on solutions in the field of wastewater collection and treatment. Solutions are marketed under the ABS brand. Tomas Wängberg emphasized the great potential in the markets in which ABS operates, focusing on the global climate issue, environmental legislation and economic development bringing an increased need for clean water and investments in infrastructure. Peter Uddfors, head of the Pulp & Paper Solutions division, which supplies sophisticated solutions for the pulp and paper industry in the fields of process flow systems and process optimisation, talked about the modern, updated
portfolio of process pumps and advanced measuring instruments that are marketed under the Scanpump and Lorentzen & Wettre brands. The division, which experienced a somewhat weaker trend during the fourth quarter last year, once again showed a positive earnings trend during the first quarter of this year.
CONTINUED GROWTH FOR PROMINENT For 2006, Germany’s ProMinent reported an 11.5% increase in external sales to 267.4 million. Chief executive Dr Andreas Dulger attributed this success to the “positive economic development in Germany as well as in the world’s most important economic centres”. The turnover development of the delta series of solenoid metering pumps introduced last year also proved to be very satisfactory. As a result of the encouraging business climate, the number of employees active in the group also increased by 6.9% to 1774 members of staff. In Heidelberg, where the group is headquartered, the workforce increased by 5.1% to 515. The company has set ambitious targets for the 2007 business year. These include establishing three new subsidiaries for international sales and service. A joint venture in the United Arab Emirates has already been agreed with the Saudi Arabian trading partner Juffali. This move is intended to provide more effective support to the booming oil and gas industry in the Persian Gulf. About 5 million will be invested at the Heidelberg site during 2007. Management expects the group’s 2007 external turnover to increase to about 300 million.
Editor Roisin Reidy Elsevier Limited PO Box 150 Kidlington Oxford OX5 1AS United Kingdom Tel: +44 (0)1865 843695 Fax: +44 (0)1865 843971 E-mail: r.reidy@elsevier. com Web: www.worldpumps. com Permissions may be sought directly from Elsevier Rights & Permissions Department, PO Box 800, Oxford OX5 1DX, UK; phone: (+44) 1865 843830, fax: (+44) 1865 853333, e-mail: [email protected]. You may also contact Rights & Permissions directly through Elsevier’s home page (http:// www.elsevier.com), selecting first ‘Customer Support’, then ‘General Information’, then Permissions Query Form’. In the USA, users may clear permissions and make payments through the Copyright Clearance Center, Inc., 222 Rosewood Drive, Danvers, MA 01923, USA; phone: (978) 7508400, fax: (978) 7504744, and in the UK through the Copyright Licensing Agency Rapid Clearance Service (CLARCS), 90 Tottenham Court Road, London W1P 0LP, UK; phone: (+44) 207 436 5931; fax: (+44) 207 436 3986. Other countries may have a local reprographic rights agency for payments. Derivative Works Subscribers may reproduce tables of contents or prepare lists of articles including abstracts for internal circulation within their institutions. Permission of the publisher is required for resale or distribution outside the institution. Permission of the publisher is required for all other derivative works, including compilations and translations. Electronic Storage or Usage Permission of the publisher is required to store or use electronically any material contained in this journal, including any article or part of an article. Contact the publisher at the address indicated. Except as outlined above, no part of this publication may be reproduced, stored in a retrieval system or transmitted in any form or by any means, electronic, mechanical, photocopying, recording or otherwise, without prior written permission of the publisher. Address permissions requests to: Elsevier Rights & Permissions Department, at the mail, fax and email addresses noted above. Notice No responsibility is assumed by the Publisher for any injury and/or damage to persons or property as a matter of products liability, negligence or otherwise, or from any use or operation of any methods, products, instructions or ideas contained in the material herein. Because of rapid advances in the medical sciences, in particular, independent verification of diagnoses and drug dosages should be made. Although all advertising material is expected to conform to ethical (medical) standards, inclusion in this publication does not constitute a guarantee or endorsement of the quality or value of such product or of the claims made of it by its manufacturer.
02167 Printed by Mayfield Press (Oxford) Limited, UK.
Pump Industry Analyst
NEWS
MHI TO LICENSE PUMP TECHNOLOGY TO BHEL Japan’s Mitsubishi Heavy Industries Ltd (MHI) and Bharat Heavy Electricals Ltd (BHEL), a governmentowned company in India, have signed an agreement under which MHI will license selected pump technologies for thermal power generation plant use. MHI will license design and production technologies for boiler feed water pumps, boiler feed water booster pumps, circulating water pumps and condensate pumps for subcritical and supercritical pressure thermal power generation plants with generation capacities of 500–1000 MW. MHI is the first Japanese company to license pump technology to a power plant maker in India. Delivery of the first pump unit produced under the agreement is expected in late 2009. BHEL has been aiming to manufacture and supply its own key equipment for power plants, including pumps, in order to accommodate plans to build supercritical pressure power plants with more than 500MW power generation capacity. MHI meanwhile has been seeking to establish a foothold into the brisk Indian power plant market.
NEW CARDO ON TRACK Cardo is developing according to plan with a strong platform for continued development as a customeroriented solution provider and an industrial group with good growth. This was the message delivered by Cardo’s president and chief executive officer (CEO) Peter Aru at a Capital
16
Markets Day in Stockholm for analysts, investors and journalists. Aro said that a new Cardo is emerging - an international, streamlined industrial group with strong brands, offering market-leading products and value-adding solutions to selected customers. “Cardo’s strategy involves targeting large international and national customers and a greater focus on value-adding solutions, where service is an important business driver for continued growth,” said Peter Aru. “We can see that the implementation of the new strategy is going according to plan and that the group has been able to report increased growth seven quarters in a row.” “An important contribution to growth will be made through our increased presence in the new emerging markets in Asia, eastern Europe and Latin America. Compared with the previous year, half of the increase in the inflow of orders during the first quarter of 2007 came from markets outside the EU,” declared Peter Aru. Tomas Wängberg, who recently took over as head of Wastewater Technology Solutions, reported a positive earnings trend, as a result of, among other things, a greater focus on solutions in the field of wastewater collection and treatment. Solutions are marketed under the ABS brand. Tomas Wängberg emphasized the great potential in the markets in which ABS operates, focusing on the global climate issue, environmental legislation and economic development bringing an increased need for clean water and investments in infrastructure. Peter Uddfors, head of the Pulp & Paper Solutions division, which supplies sophisticated solutions for the pulp and paper industry in the fields of process flow systems and process optimisation, talked about the modern, updated
portfolio of process pumps and advanced measuring instruments that are marketed under the Scanpump and Lorentzen & Wettre brands. The division, which experienced a somewhat weaker trend during the fourth quarter last year, once again showed a positive earnings trend during the first quarter of this year.
CONTINUED GROWTH FOR PROMINENT For 2006, Germany’s ProMinent reported an 11.5% increase in external sales to 267.4 million. Chief executive Dr Andreas Dulger attributed this success to the “positive economic development in Germany as well as in the world’s most important economic centres”. The turnover development of the delta series of solenoid metering pumps introduced last year also proved to be very satisfactory. As a result of the encouraging business climate, the number of employees active in the group also increased by 6.9% to 1774 members of staff. In Heidelberg, where the group is headquartered, the workforce increased by 5.1% to 515. The company has set ambitious targets for the 2007 business year. These include establishing three new subsidiaries for international sales and service. A joint venture in the United Arab Emirates has already been agreed with the Saudi Arabian trading partner Juffali. This move is intended to provide more effective support to the booming oil and gas industry in the Persian Gulf. About 5 million will be invested at the Heidelberg site during 2007. Management expects the group’s 2007 external turnover to increase to about 300 million.
Editor Roisin Reidy Elsevier Limited PO Box 150 Kidlington Oxford OX5 1AS United Kingdom Tel: +44 (0)1865 843695 Fax: +44 (0)1865 843971 E-mail: r.reidy@elsevier. com Web: www.worldpumps. com Permissions may be sought directly from Elsevier Rights & Permissions Department, PO Box 800, Oxford OX5 1DX, UK; phone: (+44) 1865 843830, fax: (+44) 1865 853333, e-mail: [email protected]. You may also contact Rights & Permissions directly through Elsevier’s home page (http:// www.elsevier.com), selecting first ‘Customer Support’, then ‘General Information’, then Permissions Query Form’. In the USA, users may clear permissions and make payments through the Copyright Clearance Center, Inc., 222 Rosewood Drive, Danvers, MA 01923, USA; phone: (978) 7508400, fax: (978) 7504744, and in the UK through the Copyright Licensing Agency Rapid Clearance Service (CLARCS), 90 Tottenham Court Road, London W1P 0LP, UK; phone: (+44) 207 436 5931; fax: (+44) 207 436 3986. Other countries may have a local reprographic rights agency for payments. Derivative Works Subscribers may reproduce tables of contents or prepare lists of articles including abstracts for internal circulation within their institutions. Permission of the publisher is required for resale or distribution outside the institution. Permission of the publisher is required for all other derivative works, including compilations and translations. Electronic Storage or Usage Permission of the publisher is required to store or use electronically any material contained in this journal, including any article or part of an article. Contact the publisher at the address indicated. Except as outlined above, no part of this publication may be reproduced, stored in a retrieval system or transmitted in any form or by any means, electronic, mechanical, photocopying, recording or otherwise, without prior written permission of the publisher. Address permissions requests to: Elsevier Rights & Permissions Department, at the mail, fax and email addresses noted above. Notice No responsibility is assumed by the Publisher for any injury and/or damage to persons or property as a matter of products liability, negligence or otherwise, or from any use or operation of any methods, products, instructions or ideas contained in the material herein. Because of rapid advances in the medical sciences, in particular, independent verification of diagnoses and drug dosages should be made. Although all advertising material is expected to conform to ethical (medical) standards, inclusion in this publication does not constitute a guarantee or endorsement of the quality or value of such product or of the claims made of it by its manufacturer.
02167 Printed by Mayfield Press (Oxford) Limited, UK.